Journal of Nuclear Medicine Technology December 2025, jnmt.125.270843; DOI: https://doi.org/10.2967/jnmt.125.270843 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.271143; DOI: https://doi.org/10.2967/jnmt.125.271143 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.270227; DOI: https://doi.org/10.2967/jnmt.125.270227 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.271119; DOI: https://doi.org/10.2967/jnmt.125.271119 ...
Journal of Nuclear Medicine Technology December 2025, jnmt.125.270581; DOI: https://doi.org/10.2967/jnmt.125.270581 ...
Reexamining Compliance with Gastric Emptying Scintigraphy Guidelines: An Updated Analysis of the Intersocietal Accreditation Commission Database Gastric Emptying Scintigraphy 2024: Still A Need for ...
Reexamining Compliance with Gastric Emptying Scintigraphy Guidelines: An Updated Analysis of the Intersocietal Accreditation Commission Database Gastric Emptying Scintigraphy 2024: Still A Need for ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
From the early use of radioiodine to the expanding reach of prostate-specific membrane antigen and somatostatin receptor ...
Theranostic programs are expanding rapidly, creating a growing need to understand how institutions implement ...
The widespread success of 177Lu-PSMA-617 for prostate cancer has generated unprecedented volume in theranostics. Prostate-specific membrane antigen–targeted theranostics is possibly the most complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback